Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma

Author: Zdzalik Daria   Dymek Barbara   Grygielewicz Paulina   Gunerka Pawel   Bujak Anna   Lamparska-Przybysz Monika   Wieczorek Maciej   Dzwonek Karolina  

Publisher: Springer Publishing Company

ISSN: 0171-5216

Source: Journal of Cancer Research and Clinical Oncology, Vol.140, Iss.4, 2014-04, pp. : 589-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content